Jonathan Moss

Professor Jonathan Moss is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His work focuses on interventional radiology, oncology, and vascular medicine, with a particular emphasis on clinical trials evaluating treatment efficacy and patient outcomes. He has contributed to landmark studies such as the CAVA trial (comparing venous access devices for chemotherapy) and the FEMME trial (assessing uterine fibroid treatments). His research spans device safety, cost-effectiveness analyses, and patient experience studies, often involving multidisciplinary collaborations. Key areas include uterine artery embolization, renal artery interventions, and carotid artery stenting. Moss’s publications frequently address translational applications of imaging technologies and interventional techniques in clinical practice.

His academic contributions include over 20 peer-reviewed articles in journals like The Lancet and New England Journal of Medicine. Notable studies include the 2007 NEJM paper comparing uterine-artery embolization with surgery, and the 2010 Lancet analysis of carotid artery stenting. He has also authored guidelines on renal denervation and contributed to systematic reviews on device-related complications in oncology. His work bridges clinical practice and health economics, emphasizing cost-utility and patient-centered outcomes in medical decision-making.

Moss has led or participated in major randomized controlled trials (e.g., ASTRAL, CAVA, FEMME) and collaborated with institutions globally. His research group’s interdisciplinary approach addresses vascular contributions to diseases like dementia and explores innovations in minimally invasive treatments. Despite no explicitly listed students, his trials involve trainees and junior researchers in clinical trial design and execution.